452 results on '"Wörns, Marcus A."'
Search Results
2. Higher scores in the Clinical Frailty Scale are associated with covert and overt hepatic encephalopathy in patients with cirrhosis
3. Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis
4. Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany
5. Structured Early detection of Asymptomatic Liver Cirrhosis: Results of the population-based liver screening program SEAL
6. Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosis
7. Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancer
8. Outcomes in patients receiving palliative chemotherapy for advanced biliary tract cancer
9. Health-related quality of life in patients with autoimmune hepatitis
10. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Kurzversion
11. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0
12. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Kurzversion
13. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0
14. Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation
15. Frailty as tested by the Clinical Frailty Scale is a risk factor for hepatorenal syndrome in patients with liver cirrhosis
16. Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure
17. Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosis
18. Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with Cirrhosis
19. Development and evaluation of a virtual reality driving test for patients with cirrhosis
20. Ergebnisse der multimodalen Therapie der hepatischen Echinokokkose
21. Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC)
22. Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis
23. Health-related quality of life in patients with compensated and decompensated liver cirrhosis
24. Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathy
25. Association Between Serum Levels of Neurofilament Light Chains and Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
26. P15 Higher Scores in the Clinical Frailty Scale Are Associated With Covert and Overt Hepatic Encephalopathy in Patients With Cirrhosis
27. Recipient liver function before liver transplantation influences post-transplantation survival in patients with HCC
28. Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis
29. A virtual reality-driving test to predict car accidents in patients with cirrhosis
30. Poorer results in the clinical frailty scale are associated with covert and overt hepatic encephalopathy in patients with cirrhosis
31. Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit Treatment
32. Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
33. S3-Leitlinie Diagnostik und Therapie biliärer Karzinome
34. Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis
35. Validation of Clinical Scoring Systems ART and ABCR after Transarterial Chemoembolization of Hepatocellular Carcinoma
36. Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives
37. Costs of a structured early detection program for advanced liver fibrosis and cirrhosis: insights on the "plus" of Check-up 35+.
38. Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver Cirrhosis
39. Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies
40. Psychisches Wohlbefinden bei Patienten mit Leberzellkarzinom
41. Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
42. Early changes in dynamic biomarkers of liver fibrosis in hepatitis C virus-infected patients treated with sofosbuvir
43. S3-Leitlinie Diagnostik und Therapie biliärer Karzinome
44. S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms
45. Clinical Predictors for Poor Quality of Life in Patients With Covert Hepatic Encephalopathy
46. Gutartige Lebertumoren – ein Update
47. Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage – a case report
48. Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin care
49. 13C-Methacetin Breath Test Predicts Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
50. Evaluation of Interleukin-6 for stepwise diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.